12.07.2015 Views

PDF, Patent Landscape Report on Atazanavir - WIPO

PDF, Patent Landscape Report on Atazanavir - WIPO

PDF, Patent Landscape Report on Atazanavir - WIPO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ACTIVITY TIMELINES OF SELECTED COMPANIESThe timelines for the inventive activity in the same companies (using earliest priority yearfor each inventi<strong>on</strong>) are presented in Figure 26. The companies are ranked <strong>on</strong> the recencyof their activity. This presentati<strong>on</strong> approach draws attenti<strong>on</strong> to recently active companies.Novartis, with the founder patents, has the earliest appearance in Figure 25, and it haspersistent later activity, as does its developer Bristol Myers Squibb. The top rank in thetable bel<strong>on</strong>gs to Enanta, a company with collaborative relati<strong>on</strong>ship to Abbott, also highlyranked in the table. Zirus (Herpes), Aicuris (synthesis) and Ranbaxy (synthesis) are allrecent entrants in the field of the collecti<strong>on</strong>. Abbott, GSK and Merck all have significant<strong>Atazanavir</strong>-relevant activity recently, mostly relating to combinati<strong>on</strong> therapy regimens orother indicati<strong>on</strong>s. Recent Boehringer and Schering activity relate to other HIV targets(Boehringer) or Hepatitis Virus (Schering). The latter observati<strong>on</strong>s are suggested by acomparis<strong>on</strong> with Figure 24 where technology emphasis was covered.Figure 26. Heat Diagram of Activity timelines32

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!